M&T Bank’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

M&T Bank’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,122	Closed	-$796K	–	1693
2023 Q2	$796K	Hold	17,122	–	–	﹤0.01%	949
2023 Q1	$490K	Hold	17,122	–	–	﹤0.01%	1125
2022 Q4	$534K	Sell	17,122 -11,354	-40%	-$370K	﹤0.01%	1079
2022 Q3	$578K	Hold	28,476	–	–	﹤0.01%	1026
2022 Q2	$442K	Buy	+28,476	New	+$490K	﹤0.01%	1063
2022 Q1	–	Sell	-8,280	Closed	-$210K	–	1670
2021 Q4	$210K	Buy	8,280 +452	+6%	+$13.2K	﹤0.01%	1435
2021 Q3	$256K	Buy	+7,828	New	+$267K	﹤0.01%	1317

M&T Bank's DICE Position: Q3 2023 in Review

M&T Bank sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 17,122 shares — an estimated $796K sold.

M&T Bank first reported a position in DICE in Q3 2021 and held it in 7 quarters. The position peaked at $796K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

M&T Bank reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
M&T Bank sold 17,122 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $796K.
M&T Bank first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
M&T Bank's DICE Therapeutics, Inc. Common Stock position peaked at $796K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on M&T Bank's 13F filing for Q3 2023, filed 2 Nov 2023.